MedTrace Logo

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

NCT00932269 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5400

Last updated 2009-07-03

No results posted yet for this study

Summary

This is a randomized cross-sectional study of the Swedish population. Blood samples will be collected from a subpopulation in order to estimate the age specific sero-prevalence of the Swedish population for diseases included in the National Immunization Program (NIP), and to affirm the population's protection against polio. To be able to recommend complementary immunizations to immigrated children, a sub study focusing on foreign born teenagers will also be done and compared to children of the same age born in Sweden.

Conditions

Sponsors & Collaborators

  • Swedish Institute for Infectious Disease Control

    lead OTHER

Principal Investigators

  • Rigmor Thorstensson, Assoc. Prof. · Swedish Institute for Infectious Disease Control

  • Eva Netterlid · Swedish Institute for Infectious Disease Control

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-05-31
Completion
2011-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00932269 on ClinicalTrials.gov